MG
RGNX icon

Michael Gelband’s Regenxbio RGNX Stock Holding History

Michael Gelband’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-115,444
Closed -$967K – 1977
2026
Q1 		$967K Buy
115,444
+59,834
+108% +$629K 0.01% 1016
2025
Q4 		$801K Buy
+55,610
New +$693K 0.01% 1068
2025
Q2 		– Sell
-62,052
Closed -$444K – 1899
2025
Q1 		$444K Sell
62,052
-43,616
-41% -$324K ﹤0.01% 1134
2024
Q4 		$817K Sell
105,668
-83,431
-44% -$783K 0.01% 1010
2024
Q3 		$1.98M Buy
+189,099
New +$2.31M 0.01% 733
2024
Q2 		– Sell
-22,744
Closed -$479K – 1908
2024
Q1 		$479K Buy
+22,744
New +$405K ﹤0.01% 1150
2023
Q4 		– Sell
-496,489
Closed -$8.17M – 1956
2023
Q3 		$8.17M Buy
496,489
+5,888
+1% +$107K 0.08% 263
2023
Q2 		$9.81M Buy
490,601
+383,658
+359% +$7.39M 0.08% 255
2023
Q1 		$2.02M Buy
106,943
+84,708
+381% +$1.87M 0.02% 871
2022
Q4 		$504K Buy
22,235
+12,537
+129% +$283K 0.01% 1171
2022
Q3 		$256K Buy
+9,698
New +$288K ﹤0.01% 1568
2020
Q3 		– Sell
-26,978
Closed -$994K – 2154
2020
Q2 		$994K Buy
+26,978
New +$1.01M 0.03% 752
2019
Q3 		– Sell
-13,879
Closed -$713K – 1589
2019
Q2 		$713K Buy
+13,879
New +$693K 0.03% 356

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Michael Gelband's RGNX Position: Q2 2026 in Review

Michael Gelband sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 115,444 shares — an estimated $967K sold.

Michael Gelband first reported a position in RGNX in Q2 2019 and held it in 13 quarters. The position peaked at $9.81M in Q2 2023. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Michael Gelband reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 115,444 Regenxbio shares in Q2 2026, an estimated $967K.
  • Michael Gelband first reported a position in Regenxbio in Q2 2019 and held it in 13 quarters.
  • Michael Gelband's Regenxbio position peaked at $9.81M in Q2 2023.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.